Buske C - Search Results

1

An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia.

Herold T, Jurinovic V, Metzeler KH, Boulesteix AL, Bergmann M, Seiler T, Mulaw M, Thoene S, Dufour A, Pasalic Z, Schmidberger M, Schmidt M, Schneider S, Kakadia PM, Feuring-Buske M, Braess J, Spiekermann K, Mansmann U, Hiddemann W, Buske C, Bohlander SK. Herold T, et al. Among authors: buske c. Leukemia. 2011 Oct;25(10):1639-45. doi: 10.1038/leu.2011.125. Epub 2011 May 31. Leukemia. 2011. PMID: 21625232 No abstract available.

2

Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.

Buske C, Hiddemann W, Wörmann B. Buske C, et al. Cell Biol Int. 1994 Nov;18(11):1049-58. doi: 10.1006/cbir.1994.1028. Cell Biol Int. 1994. PMID: 7894389

3

TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf G, Schäfer C, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Mar;11(3):386-92. doi: 10.1038/sj.leu.2400586. Leukemia. 1997. PMID: 9067578

4

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1997 Apr;25(4):329-37. Exp Hematol. 1997. PMID: 9131008

5

Human herpesvirus-8 (HHV-8) DNA associated with anaplastic large cell lymphoma of the B-cell type in an HIV-1-positive patient.

Buske C, Hannig H, Hiddemann W, Bodemer W. Buske C, et al. Int J Cancer. 1997 Oct 9;73(2):303-4. doi: 10.1002/(sici)1097-0215(19971009)73:2<303::aid-ijc23>3.0.co;2-e. Int J Cancer. 1997. PMID: 9335459 Free article. No abstract available.

6

In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.

Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Nov;11(11):1862-7. doi: 10.1038/sj.leu.2400822. Leukemia. 1997. PMID: 9369419

7

[Systemic therapy of low malignancy non-Hodgkin lymphomas].

Wörmann B, Buske C, Hiddemann W. Wörmann B, et al. Among authors: buske c. Praxis (Bern 1994). 1998 Jun 3;87(23):806-11. Praxis (Bern 1994). 1998. PMID: 9654987 Review. German.

8

TGF-beta and its receptor complex in leukemic B-cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Griesinger F, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1998 Nov;26(12):1155-61. Exp Hematol. 1998. PMID: 9808055

9

Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.

Feuring-Buske M, Haase D, Buske C, Hiddemann W, Wörmann B. Feuring-Buske M, et al. Among authors: buske c. Leukemia. 1999 Mar;13(3):386-92. doi: 10.1038/sj.leu.2401300. Leukemia. 1999. PMID: 10086729

10

[New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].

Buske C, Feuring-Buske M, Unterhalt M, Hiddemann W. Buske C, et al. Dtsch Med Wochenschr. 1999 Jul 9;124(27):842-7. doi: 10.1055/s-2007-1024429. Dtsch Med Wochenschr. 1999. PMID: 10432945 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page